William Alexander Morton

Title
InstitutionMedical University of South Carolina
DepartmentSCCP College of Pharmacy Dean's Office - MUSC Campus
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Morton WA, Stockton GG. Methylphenidate Abuse and Psychiatric Side Effects. Prim Care Companion J Clin Psychiatry. 2000 Oct; 2(5):159-164. PMID: 15014637.
      Citations:    
    2. Emmanuel NP, Brawman-Mintzer O, Morton WA, Book SW, Johnson MR, Lorberbaum JP, Ballenger JC, Lydiard RB. Bupropion-SR in treatment of social phobia. Depress Anxiety. 2000; 12(2):111-3. PMID: 11091936.
      Citations:    
    3. DeVane CL, Ware MR, Emmanuel NP, Brawman-Mintzer O, Morton WA, Villarreal G, Lydiard RB. Evaluation of the efficacy, safety and physiological effects of fluvoxamine in social phobia. Int Clin Psychopharmacol. 1999 Nov; 14(6):345-51. PMID: 10565801.
      Citations:    
    4. Morton WA. Cocaine and Psychiatric Symptoms. Prim Care Companion J Clin Psychiatry. 1999 Aug; 1(4):109-113. PMID: 15014683.
      Citations:    
    5. Johnson MR, Marazziti D, Brawman-Mintzer O, Emmanuel NP, Ware MR, Morton WA, Rossi A, Cassano GB, Lydiard RB. Abnormal peripheral benzodiazepine receptor density associated with generalized social phobia. Biol Psychiatry. 1998 Feb 15; 43(4):306-9. PMID: 9513742.
      Citations:    
    6. Morton WA, Mendenhall AR, Windsor PG, Lydiard B. Clinical psychopharmacy consultations: acceptance of recommendations on an adult inpatient psychiatric unit. Hosp Pharm. 1995 Sep; 30(9):786-90. PMID: 10151283.
      Citations:    
    7. Morton WA, Sonne SC, Verga MA. Venlafaxine: a structurally unique and novel antidepressant. Ann Pharmacother. 1995 Apr; 29(4):387-95. PMID: 7633018.
      Citations:    
    8. Brady KT, Lydiard RB, Kellner CH, Joffe R, Laird LK, Morton WA, Steele TE. A comparison of the effects of imipramine and fluvoxamine on the thyroid axis. Biol Psychiatry. 1994 Dec 01; 36(11):778-9. PMID: 7858077.
      Citations:    
    9. Sonne SC, Brady KT, Morton WA. Substance abuse and bipolar affective disorder. J Nerv Ment Dis. 1994 Jun; 182(6):349-52. PMID: 8201307.
      Citations:    
    10. Jackson CW, Morton WA, Lydiard RB. Pharmacologic management of obsessive-compulsive disorder. South Med J. 1994 Mar; 87(3):310-21. PMID: 8134850.
      Citations:    
    11. Morton WA, Laird LK, Crane DF, Partovi N, Frye LH. A prediction model for identifying alcohol withdrawal seizures. Am J Drug Alcohol Abuse. 1994; 20(1):75-86. PMID: 8192136.
      Citations:    
    12. Laird LK, Lydiard RB, Morton WA, Steele TE, Kellner C, Thompson NM, Ballenger JC. Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients. J Clin Psychiatry. 1993 Jun; 54(6):224-8. PMID: 8331091.
      Citations:    
    13. Johnson MR, Lydiard RB, Morton WA, Laird LK, Steele TE, Kellner CH, Ballenger JC. Effect of fluvoxamine, imipramine and placebo on catecholamine function in depressed outpatients. J Psychiatr Res. 1993 Apr-Jun; 27(2):161-72. PMID: 8396179.
      Citations:    
    14. Morton WA, Sonne SC, Lydiard RB. Lithium side effects in the medically ill. Int J Psychiatry Med. 1993; 23(4):357-82. PMID: 8175248.
      Citations:    
    15. Lydiard RB, Morton WA, Emmanuel NP, Zealberg JJ, Laraia MT, Stuart GW, O'Neil PM, Ballenger JC. Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder. Psychopharmacol Bull. 1993; 29(2):183-8. PMID: 8290663.
      Citations:    
    16. Santos AB, Morton WA. Use of benzodiazepines to improve management of manic agitation. Hosp Community Psychiatry. 1989 Oct; 40(10):1069-71. PMID: 2680879.
      Citations:    
    17. Lydiard RB, Laird LK, Morton WA, Steele TE, Kellner C, Laraia MT, Ballenger JC. Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression. Psychopharmacol Bull. 1989; 25(1):68-70. PMID: 2505304.
      Citations:    
    18. Doyal LE, Morton WA, Crane DF. Antihypertensive drug therapy in alcohol dependence. Psychosomatics. 1988; 29(3):301-6. PMID: 3406346.
      Citations:    
    19. Steele TE, Morton WA. Salicylate-induced delirium. Psychosomatics. 1986 Jun; 27(6):455-6. PMID: 3737835.
      Citations:    
    20. Doyal LE, Morton WA. The clinical usefulness of lithium as an antidepressant. Hosp Community Psychiatry. 1984 Jul; 35(7):685-91. PMID: 6378754.
      Citations:    
    Morton's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (108)
    Explore
    _
    Co-Authors (11)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _